FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+9.15%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$196M
AUM Growth
+$196M
(+11%)
Cap. Flow
+$9.87M
Cap. Flow
% of AUM
5.04%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
69
New
3
Increased
33
Reduced
3
Closed
7
Top Buys
| 1 |
Insmed
INSM
|
$4.37M |
| 2 |
TEAR
TearLab Corporation
TEAR
|
$3.97M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$2.22M |
| 4 |
Verastem
VSTM
|
$2.12M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$1.92M |
Top Sells
| 1 |
Vanda Pharmaceuticals
VNDA
|
$3.29M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
$2.94M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$2.61M |
| 4 |
Align Technology
ALGN
|
$2.05M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$2M |
Sector Composition
| 1 | Healthcare | 88.63% |
| 2 | Consumer Staples | 0.8% |
| 3 | Financials | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.3B
| $3.07M | 1.57% |
24,606
+2,544
| +12% | +$317K |
|
27
Alkermes
ALKS
$4.95B
| $3.02M | 1.54% |
49,597
-21,264
| -30% | -$1.3M |
|
|
CPHD
28
DELISTED
Cepheid Inc
CPHD
| $2.83M | 1.45% |
49,784
+5,026
| +11% | +$286K |
|
29
STAAR Surgical
STAA
$1.35B
| $2.53M | 1.29% |
340,662
+34,281
| +11% | +$255K |
|
30
LeMaitre Vascular
LMAT
$2.14B
| $2.45M | 1.25% |
292,119
+28,973
| +11% | +$243K |
|
31
HealthStream
HSTM
$832M
| $2.31M | 1.18% |
91,690
+9,245
| +11% | +$233K |
|
32
Vertex Pharmaceuticals
VRTX
$102B
| $2.28M | 1.17% |
19,365
+1,774
| +10% | +$209K |
|
|
AMAG
33
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $2.22M | 1.14% |
+40,695
| New | +$2.22M |
|
|
BLUE
34
DELISTED
bluebird bio
BLUE
| $2.14M | 1.09% |
17,718
+1,710
| +11% | +$206K |
|
|
35
Verastem
VSTM
$585M
| $2.12M | 1.08% |
+207,922
| New | +$2.12M |
|
|
STKL
36
SunOpta
STKL
$741M
| $1.57M | 0.8% |
147,418
+14,434
| +11% | +$153K |
|
37
Cytokinetics
CYTK
$5.98B
| $1.35M | 0.69% |
199,014
+19,825
| +11% | +$134K |
|
|
PETX
38
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.03M | 0.53% |
64,206
+6,141
| +11% | +$98.3K |
|
|
ENDP
39
DELISTED
Endo International plc
ENDP
| $732K | 0.37% |
8,161
| – | – |
|
40
United Therapeutics
UTHR
$17.7B
| $659K | 0.34% |
3,820
| – | – |
|
41
Elevance Health
ELV
$72.4B
| $632K | 0.32% |
4,095
| – | – |
|
42
Humana
HUM
$37.5B
| $630K | 0.32% |
3,540
| – | – |
|
|
AGN
43
DELISTED
Allergan plc
AGN
| $606K | 0.31% |
2,035
| – | – |
|
44
Novartis
NVS
$248B
| $599K | 0.31% |
6,070
| – | – |
|
45
Viatris
VTRS
$12.3B
| $580K | 0.3% |
9,775
| – | – |
|
|
AET
46
DELISTED
Aetna Inc
AET
| $556K | 0.28% |
5,215
| – | – |
|
47
Bristol-Myers Squibb
BMY
$96.7B
| $535K | 0.27% |
8,290
| – | – |
|
|
CELG
48
DELISTED
Celgene Corp
CELG
| $493K | 0.25% |
4,280
| – | – |
|
49
Becton Dickinson
BDX
$54.3B
| $487K | 0.25% |
3,395
+600
| +21% | +$86.1K |
|
50
Steris
STE
$23.9B
| $445K | 0.23% |
6,330
| – | – |
|